FAQs

Home > The Evidence > FAQs

FAQs

What is Xelma® extracellular matrix protein?

Xelma® consists of amelogenin proteins, a thickening agent propylene glycol alginate (PGA) and water.

Xelma® has been proven to improve healing in hard to heal ulcers.

FAQs: Venous leg ulcers (908kb) | Diabetic foot ulcers (797kb)

	How Xelma works When applied to the wound bed Xelma restores the damaged proteins providing an extracellular matrix protien for cell attachment. FIND OUT MORE

	What is the extracellular matrix? The extracellular matrix (ECM) plays and important role in the wound healing process. It acts as a scaffold within the wound, providing a framework to which cells can attach, proliferate and synthesise... FIND OUT MORE

	How to use Xelma Xelma is indicated for hard-to-heal ulcers - primarliy, venous leg ulcers. Xelma can be used under compression therapy. FIND OUT MORE!

XELMA UPDATES

Confirmed efficacy of Xelma in the treatment of hard-to-heal wounds offers new hope for patients and clinicians.

New algorithm for the management of hard-to-heal venous leg ulcers.

Build: 1.0.1.1 (9/18/2009 12:15:54 AM)